Gila Therapeutics is a clinical-stage pharmaceutical company developing a therapy for obesity.
Gila Therapeutics has raised $356K in total funding. The most recent round was Seed. The last funding was announced in November 2022.
Gila Therapeutics's investors include Slater Technology Fund, Broadview Ventures, Argonautic Ventures, Harvard Business School Angels Chicago.
Gila Therapeutics is headquartered in Minneapolis, United States.
Gila Therapeutics is a clinical-stage pharmaceutical company developing a therapy for obesity.
Gila Therapeutics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Gila Therapeutics — Funding & Investors." VCBacked, November 29, 2022, https://www.vcbacked.co/company/gila-therapeutics. Accessed August 13, 2026.
VCBacked. (2022). Gila Therapeutics — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/gila-therapeutics
{{cite web |title=Gila Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/gila-therapeutics |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated